Skip to main content
SpringerLink
Log in

Systematic review: cardiovascular risk and mortality with rosiglitazone

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Wallach JD, et al. Updating insights into rosiglitazone and cardiovascular risk through shared data: individual patient and summary level meta-analyses. British Medical Journal 368: 5 Feb 2020. Available from: URL: https://doi.org/10.1136/bmj.l7078

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Systematic review: cardiovascular risk and mortality with rosiglitazone. Reactions Weekly 1791, 13 (2020). https://doi.org/10.1007/s40278-020-74858-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-74858-5

Search

Navigation